Aptus Capital Advisors LLC Sells 235 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Aptus Capital Advisors LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 466 shares of the exchange traded fund’s stock after selling 235 shares during the quarter. Aptus Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $42,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Ameritas Advisory Services LLC lifted its position in shares of SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after buying an additional 1,137 shares during the last quarter. Alliancebernstein L.P. purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $607,000. Van ECK Associates Corp bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $1,497,000. Parallel Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Quantbot Technologies LP raised its position in shares of SPDR S&P Biotech ETF by 31.8% in the fourth quarter. Quantbot Technologies LP now owns 48,294 shares of the exchange traded fund’s stock valued at $4,349,000 after purchasing an additional 11,663 shares during the period.

SPDR S&P Biotech ETF Trading Down 2.1 %

XBI opened at $76.39 on Friday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The company has a market cap of $4.85 billion, a PE ratio of 11.47 and a beta of 1.00. The company has a 50 day moving average of $80.77 and a 200 day moving average of $89.22.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.